Patif 0.2% Eye Drop
By Patif
Rx
5ml Eye Drop in a Packet

Composition
Olopatadine(0.2% w/v)

Manufacturer - Neomedix Healthcare India Private Limited
Plot No. -13 , Sector -5, Industrial Area, Parwanoo, Distt. Solan (H.P) India

Expires on or after
September, 2026

liver
No interaction has been found or established between Patif 0.2% Eye Drop and liver function. It is important to note that there is no specific safety advice related to liver issues available for this medication. You can use Patif 0.2% Eye Drop as prescribed without significant concerns regarding its impact on liver health. If you have any specific liver concerns or conditions, it is advisable to consult with your doctor for personalized guidance before using this medication.

kidney
No interaction found/established regarding kidney issues with Patif 0.2% Eye Drop.

alcohol
No interaction found between alcohol and Patif 0.2% Eye Drop.

driving
After using Patif 0.2% Eye Drop, your vision may be blurry temporarily. Avoid driving until your vision is clear to ensure safety on the road.

pregnancy
Patif 0.2% Eye Drop may not be safe during pregnancy. Limited human studies and animal research suggest potential harm to the baby. Your doctor will assess the benefits and risks before prescribing. Consult your doctor for guidance.

breastfeeding
Patif 0.2% Eye Drop is considered safe for breastfeeding. Minimal data indicates no major risks for the baby.
Habit Forming | No |
Chemical Class | Dibenzoxepine Derivative |
Therapeutic Class | - |
Action Class | H1 Antihistaminics (second Generation) |
₹170
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024